RBC Capital Markets reiterated its Outperform rating on one well-known MedTech stock in a note this week, calling it a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot List Hot List Pro

Abbott Labs (ABT) PT Raised to $162 at BarclaysOctober 17, 2025 2:55 AM UBS Reiterates Buy Rating on Abbott Labs (ABT), Highlights Buying OpportunityOctober 16, 2025 9:30 AM Benchmark Reiterates Buy Rating on Abbott Labs (ABT), Following In-Line Q3 ResultsOctober 16, 2025 8:31 AM Abbott Labs (ABT) PT Raised to $145 at JPMorganOctober 16, 2025 7:29 AM RBC Capital Reiterates Outperform Rating on Abbott Labs (ABT), 'dips create opportunity'October 16, 2025 6:17 AM Abbott Labs (ABT) PT Raised to $150 at Bernstein SocGen GroupOctober 16, 2025 6:08 AM Abbott Labs (ABT) PT Raised to $146 at Wells FargoOctober 16, 2025 5:02 AM Abbott Labs (ABT) PT Raised to $146 at JefferiesOctober 16, 2025 4:59 AM Abbott reports in-line third-quarter results, affirms guidance; shares slipOctober 15, 2025 7:44 AM Abbott revenue misses as diagnostics, nutrition weakness clouds medical devices liftOctober 15, 2025 7:38 AM Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS GuidanceOctober 15, 2025 7:32 AM Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year GuidanceOctober 15, 2025 7:30 AM Raymond James expects modest upside for this MedTech stock in Q3 resultsOctober 15, 2025 5:00 AM